Dodge & Cox
- SEC CIK
- 0000200217
- Latest filing
- Aug 13, 2026
CVS holding history
CVS Health Corp in every 13F filed by Dodge & Cox, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CVS overviewAll 13F holders of CVSFull Q2 2026 holdings
- Shares (Q2 2026)
- 50,012,765
- Value
- $5.17B
- % of portfolio
- 2.7%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 50,012,765 | $5.17B | 2.7% | −1,767,351−3.4% | Reduced | Holders |
| Q1 2026 | 51,780,116 | $3.72B | 2.0% | −10,729,872−17.2% | Reduced | Holders |
| Q4 2025 | 62,509,988 | $4.96B | 2.7% | −10,666,598−14.6% | Reduced | Holders |
| Q3 2025 | 73,176,586 | $5.52B | 3.0% | −112,180−0.2% | Reduced | Holders |
| Q2 2025 | 73,288,766 | $5.06B | 2.8% | −170,356−0.2% | Reduced | Holders |
| Q1 2025 | 73,459,122 | $4.98B | 2.8% | +3,353,223+4.8% | Added | Holders |
| Q4 2024 | 70,105,899 | $3.15B | 1.8% | +7,075,209+11.2% | Added | Holders |
| Q3 2024 | 63,030,690 | $3.96B | 2.2% | +1,347,347+2.2% | Added | Holders |
| Q2 2024 | 61,683,343 | $3.64B | 2.2% | +20,670,800+50.4% | Added | Holders |
| Q1 2024 | 41,012,543 | $3.27B | 1.9% | +10,599,153+34.9% | Added | Holders |
| Q4 2023 | 30,413,390 | $2.40B | 1.5% | +3,690,408+13.8% | Added | Holders |
| Q3 2023 | 26,722,982 | $1.87B | 1.3% | +10,698,560+66.8% | Added | Holders |
| Q2 2023 | 16,024,422 | $1.11B | 0.7% | +3,417,573+27.1% | Added | Holders |
| Q1 2023 | 12,606,849 | $936.8M | 0.6% | +5,9620.0% | Added | Holders |
| Q4 2022 | 12,600,887 | $1.17B | 0.8% | −871,885−6.5% | Reduced | Holders |
| Q3 2022 | 13,472,772 | $1.28B | 1.0% | −236,945−1.7% | Reduced | Holders |
| Q2 2022 | 13,709,717 | $1.27B | 0.9% | −360,565−2.6% | Reduced | Holders |
| Q1 2022 | 14,070,282 | $1.42B | 0.9% | −543,390−3.7% | Reduced | Holders |
| Q4 2021 | 14,613,672 | $1.51B | 0.9% | −676,550−4.4% | Reduced | Holders |
| Q3 2021 | 15,290,222 | $1.30B | 0.8% | −432,852−2.8% | Reduced | Holders |
| Q2 2021 | 15,723,074 | $1.31B | 0.9% | −441,911−2.7% | Reduced | Holders |
| Q1 2021 | 16,164,985 | $1.22B | 0.9% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.